Cargando…
PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431396/ http://dx.doi.org/10.1097/01.HS9.0000851376.34315.4f |
_version_ | 1784780044189564928 |
---|---|
author | Schaff, L. Lobbous, M. Carlow, D. DeAngelis, L. Nabors, L. B. Grommes, C. |
author_facet | Schaff, L. Lobbous, M. Carlow, D. DeAngelis, L. Nabors, L. B. Grommes, C. |
author_sort | Schaff, L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94313962022-08-31 PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC Schaff, L. Lobbous, M. Carlow, D. DeAngelis, L. Nabors, L. B. Grommes, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431396/ http://dx.doi.org/10.1097/01.HS9.0000851376.34315.4f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Schaff, L. Lobbous, M. Carlow, D. DeAngelis, L. Nabors, L. B. Grommes, C. PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
title | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
title_full | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
title_fullStr | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
title_full_unstemmed | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
title_short | PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC |
title_sort | pb2136: planned-use glucarpidase for outpatient high dose methotrexate (hd-mtx) administration in patients with cns lymphoma (cnsl) during the covid-19 pandemic |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431396/ http://dx.doi.org/10.1097/01.HS9.0000851376.34315.4f |
work_keys_str_mv | AT schaffl pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT lobbousm pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT carlowd pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT deangelisl pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT naborslb pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic AT grommesc pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic |